Carmell(us:CTCX)

    0.2847

    +26.20%

    Updated on 2024-12-25

    Open:0.4328
    Close:0.2847
    High:0.4796
    Low:0.2610
    Pre Close:0.2256
    Volume:61.35M
    Amount:23.69M
    Turnover:293.47%
    Shares:20.91M
    MarketCap:5.95M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3017232175711.11%346
    2024-03-3118229621411.86%167
    2023-12-311823050759.98%356
    2023-09-3047231337210.02%11135
    2023-06-30481295055965.51%8617
    2023-03-31451303167765.92%5513
    2022-12-31451290291665.27%5312
    2022-09-30411288667965.19%864
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Meteora Capital, Llc17398588.99%-3165-0.18%
    2024-03-31Vanguard Group Inc1725400.89%30491.80%
    2024-03-31Carnegie Mellon University1030610.53%0
    2024-03-31Geode Capital Management, Llc899070.46%7520.84%
    2024-03-31Linden Advisors Lp750000.39%0
    2024-03-31Northern Trust Corp539100.28%-4448-7.62%
    2024-03-31Blackrock Inc.315860.16%0
    2024-03-31Xtx Topco Ltd140710.07%-2762-16.41%
    2024-03-31Hubbell Strickland Wealth Management, Llc125480.06%12548
    2024-03-31Morgan Stanley20810.01%0

    About

    Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.
    Address:2403 Sidney Street,Suite 300

    Market Movers